Beijing Leadman Biochemistry Co.,Ltd. (SHE:300289)

SHE:300289 Revenue

Beijing Leadman Biochemistry had revenue of 259.92M CNY in the quarter ending September 30, 2026, with 183.26% growth. This brings the company's total for the last twelve months to 485.94M, up 42.65% year-over-year. In the year 2025, Beijing Leadman Biochemistry had annual revenue of 326.31M, down -11.86%. That makes Beijing Leadman Biochemistry the 25,128th largest company in the world by revenue and 4,487th in China.

• Revenue (ttm): 485.94M
• Revenue Growth: +42.65%
• P/S Ratio: 6.72
• Revenue / Employee: 1.16M
• Employees: 405
• Market Cap: 3.26B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Biological and Pharmaceutical Products 285.64M 87.5%
• Property Leasing 38.53M 11.8%
• Serve 2.14M 0.7%

By Geography

Chart

• East China 135.61M 41.6%
• North China 80.00M 24.5%
• South China 41.65M 12.8%
• Central China 38.49M 11.8%
• Northeast Region 13.83M 4.2%
• Southwest Region 8.67M 2.7%
• Northwest Territories 8.06M 2.5%

Fiscal year ended Dec 31, 2025 See the full SHE:300289 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	326.31M	-43.92M	-11.86%
Dec 31, 2024	370.23M	-91.33M	-19.79%
Dec 31, 2023	461.55M	-244.42M	-34.62%
Jan 1, 2023	705.98M	141.92M	25.16%
Jan 1, 2022	564.06M	92.55M	19.63%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error